logo-loader
viewIntec Pharma

Intec Pharma accordion pill technology looking to change the game in drug delivery

Intec Pharma Ltd (NASDAQ:NTEC) CEO Jeffery Meckler talked with Proactive’s Steve Darling at the 12th annual LD Micro Conference. The Jerusalem, Israel-based clinical-stage biopharmaceutical company develops drugs based on its proprietary Accordion Pill platform technology. The innovative Accordion Pill oral drug delivery system boosts the potency of drugs by utilizing efficient gastric retention and specific release mechanism. 

Quick facts: Intec Pharma

Price: 0.515 USD

NASDAQ:NTEC
Market: NASDAQ
Market Cap: $18.36 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bulls, Bears & Brokers: Alto Capital’s Tony Locantro on Nyrada IPO and small...

Alto Capital investment manager and stock market commentator Tony Locantro updates Proactive on this week's listing of Nyrada Inc (ASX:NYR), a spin-off of Noxopharm Ltd’s (ASX:NOX). He discusses the reasons for the spin-off, including some of the recent and expected trading patterns. Locantro...

1 week, 1 day ago

2 min read